These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 39205220)

  • 21. Inhibition of the OAS/RNase L pathway by viruses.
    Drappier M; Michiels T
    Curr Opin Virol; 2015 Dec; 15():19-26. PubMed ID: 26231767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of the 5' untranslated region in SARS-CoV-2 genome and its specific recognition by innate immune system
    Bignon E; Miclot T; Terenzi A; Barone G; Monari A
    Chem Commun (Camb); 2022 Feb; 58(13):2176-2179. PubMed ID: 35060977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 2'-5'-oligoadenylate synthetase 3 enzyme potently synthesizes the 2'-5'-oligoadenylates required for RNase L activation.
    Ibsen MS; Gad HH; Thavachelvam K; Boesen T; Desprès P; Hartmann R
    J Virol; 2014 Dec; 88(24):14222-31. PubMed ID: 25275129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quelling an innate response to dsRNA.
    Ogden KM; Prasad BV
    Oncotarget; 2015 Oct; 6(30):28535-6. PubMed ID: 26356565
    [No Abstract]   [Full Text] [Related]  

  • 25. Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L.
    Anderson BR; Muramatsu H; Jha BK; Silverman RH; Weissman D; Karikó K
    Nucleic Acids Res; 2011 Nov; 39(21):9329-38. PubMed ID: 21813458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon.
    Birdwell LD; Zalinger ZB; Li Y; Wright PW; Elliott R; Rose KM; Silverman RH; Weiss SR
    J Virol; 2016 Jan; 90(6):3160-72. PubMed ID: 26739051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OASes and STING: adaptive evolution in concert.
    Mozzi A; Pontremoli C; Forni D; Clerici M; Pozzoli U; Bresolin N; Cagliani R; Sironi M
    Genome Biol Evol; 2015 Mar; 7(4):1016-32. PubMed ID: 25752600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rotavirus NSP1 Subverts the Antiviral Oligoadenylate Synthetase-RNase L Pathway by Inducing RNase L Degradation.
    Dai J; Yi G; Philip AA; Patton JT
    mBio; 2022 Dec; 13(6):e0299522. PubMed ID: 36413023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel RNA molecular signature for activation of 2'-5' oligoadenylate synthetase-1.
    Vachon VK; Calderon BM; Conn GL
    Nucleic Acids Res; 2015 Jan; 43(1):544-52. PubMed ID: 25477390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [OAS genes and susceptibility to West Nile virus].
    Guénet JL; Després P
    Med Sci (Paris); 2003 Jan; 19(1):9-12. PubMed ID: 12836183
    [No Abstract]   [Full Text] [Related]  

  • 31. Structural mechanism of sensing long dsRNA via a noncatalytic domain in human oligoadenylate synthetase 3.
    Donovan J; Whitney G; Rath S; Korennykh A
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):3949-54. PubMed ID: 25775560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-type-specific effects of RNase L on viral induction of beta interferon.
    Banerjee S; Chakrabarti A; Jha BK; Weiss SR; Silverman RH
    mBio; 2014 Feb; 5(2):e00856-14. PubMed ID: 24570368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Length dependent activation of OAS proteins by dsRNA.
    Wang Y; Holleufer A; Gad HH; Hartmann R
    Cytokine; 2020 Feb; 126():154867. PubMed ID: 31629990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure of the 2'-specific and double-stranded RNA-activated interferon-induced antiviral protein 2'-5'-oligoadenylate synthetase.
    Hartmann R; Justesen J; Sarkar SN; Sen GC; Yee VC
    Mol Cell; 2003 Nov; 12(5):1173-85. PubMed ID: 14636576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of 2' 5'-oligoadenylate synthetase by stem loops at the 5'-end of the West Nile virus genome.
    Deo S; Patel TR; Dzananovic E; Booy EP; Zeid K; McEleney K; Harding SE; McKenna SA
    PLoS One; 2014; 9(3):e92545. PubMed ID: 24651762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNase L Antiviral Activity Is Not a Critical Component of the Oas1b-Mediated Flavivirus Resistance Phenotype.
    Madden JC; Cui D; Brinton MA
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defects in TLR3 expression and RNase L activation lead to decreased MnSOD expression and insulin resistance in muscle cells of obese people.
    Fabre O; Breuker C; Amouzou C; Salehzada T; Kitzmann M; Mercier J; Bisbal C
    Cell Death Dis; 2014 Mar; 5(3):e1136. PubMed ID: 24651439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family.
    Eskildsen S; Justesen J; Schierup MH; Hartmann R
    Nucleic Acids Res; 2003 Jun; 31(12):3166-73. PubMed ID: 12799444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent Loss-of-Function Mutations Reveal Costs to OAS1 Antiviral Activity in Primates.
    Carey CM; Govande AA; Cooper JM; Hartley MK; Kranzusch PJ; Elde NC
    Cell Host Microbe; 2019 Feb; 25(2):336-343.e4. PubMed ID: 30713099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term balancing selection at the antiviral gene OAS1 in Central African chimpanzees.
    Ferguson W; Dvora S; Fikes RW; Stone AC; Boissinot S
    Mol Biol Evol; 2012 Apr; 29(4):1093-103. PubMed ID: 22104212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.